Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Post-Approval Clinical Trial of the PCM® Cervical Disc

ClinicalTrials.gov ID: NCT01905930

Public ClinicalTrials.gov record NCT01905930. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Multi-Center, Post-Approval Clinical Trial Evaluating the Long-Term (7 Year) Safety and Effectiveness of the PCM® Cervical Disc

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

On October 26, 2012, the FDA granted Premarket Approval (PMA) for the PCM Cervical Disc. PCM Cervical Disc is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from C3-C4 to C6-C7 following single-level discectomy for intractable radiculopathy (arm pain and/or a neurological deficit), with or without neck pain, or myelopathy due to a single-level abnormality localized to the disc space, and manifested by at least one of the following conditions confirmed by radiographic imaging (CT, MRI, X-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels. The purpose of this post-approval study is to evaluate the long-term (7 year) safety and effectiveness of the PCM Cervical Disc.

Study identification

NCT ID
NCT01905930
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NuVasive
Industry
Enrollment
494 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2013
Primary completion
Mar 31, 2015
Completion
Mar 31, 2015
Last update posted
May 20, 2015

2013 – 2015

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
Spine Group Beverly Hills Beverly Hills California 90212
Denver Spine Greenwood Village Colorado 80111
Midwest Orthopedic Associates at Rush Chicago Illinois 60612
Chicago Back Institute Chicago Illinois 60625
Goodman Campbell Brain and Spine Indianapolis Indiana 46260
Towson Orthopedic Associates Towson Maryland 21204
Wm. Beaumont Hospital Southfield Michigan 48034
Columbia Orthopedic Research Columbia Missouri 65201
Buffalo Spine Surgery Lockport New York 14094
Institute for Spine Care Syracuse New York 13202
The Cleveland Clinic Cleveland Ohio 44195
Neuroscience Specialists Oklahoma City Oklahoma 73120
The Rothman Institute Philadelphia Pennsylvania 19107
Scott and White Memorial Hospital Temple Texas 76508
Virginia Brain and Spine Winchester Virginia 22601
Olympia Othopaedic Associates Olympia Washington 98502
Madigan Army Medical Center Tacoma Washington 98431-1100
NeuroSpine Center of Wisconsin Appleton Wisconsin 54913

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01905930, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 20, 2015 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01905930 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →